Atrioventricular Block clinical trials at UCSF
1 research study open to eligible people
Atrioventricular block is a delay or blockage of electrical signals in the heart. UCSF is running studies that focus on fetal atrioventricular block detected in the second trimester of pregnancy. These clinical trials aim to find better care for pregnant individuals dealing with this issue.
Showing trials for
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
open to eligible females ages 18 years and up
Fetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with maternal anti-Ro autoantibodies and results in death…
San Francisco, California and other locations
Last updated: